These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36650390)

  • 21. Examining the Interplay Between Preexposure Prophylaxis (PrEP) and Gender-Related Stigmas as Barriers for PrEP Uptake Among Transgender Women in Tijuana, Mexico: A Mixed-Methods Study.
    Algarin AB; Cirilo A; Pitpitan EV; Pines HA; Padilla-Garcia R; Zapien-Vasquez MF; Navarro-Alvarez S; Smith LR
    AIDS Behav; 2024 Nov; 28(11):3655-3665. PubMed ID: 39080200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers and motivators to pre-exposure prophylaxis uptake among Black and Latina transgender women in Los Angeles: perspectives of current PrEP users.
    Nieto O; Fehrenbacher AE; Cabral A; Landrian A; Brooks RA
    AIDS Care; 2021 Feb; 33(2):244-252. PubMed ID: 32449399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women.
    Shorrock F; Alvarenga A; Hailey-Fair K; Vickroy W; Cos T; Kwait J; Trexler C; Wirtz AL; Galai N; Beyrer C; Celentano D; Arrington-Sanders R
    AIDS Patient Care STDS; 2022 May; 36(5):194-203. PubMed ID: 35507322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV Antiretroviral Treatment and Pre-exposure Prophylaxis in Transgender Individuals.
    Poteat TC; Radix A
    Drugs; 2020 Jul; 80(10):965-972. PubMed ID: 32451925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shared decision making for HIV pre-exposure prophylaxis (PrEP) with black transgender women.
    McNulty MC; Acree ME; Kerman J; Williams HHS; Schneider JA
    Cult Health Sex; 2022 Aug; 24(8):1033-1046. PubMed ID: 33983866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
    Klein A; Golub SA
    AIDS Patient Care STDS; 2019 Jun; 33(6):262-269. PubMed ID: 31166785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intention to Use Different Formulations of Longer Acting HIV Pre-Exposure Prophylaxis Among Transgender and Gender Expansive Individuals: The Roles of Social Vulnerability and Medical Mistrust.
    Schnarrs PW; Zuñiga J; Benitez G; Fliedner P; Norwood A; Croll M; Oviedo LDS; Buchorn J; Oeffinger J; Lane R; Schelling E; Pham G; Pate T; Arnold EM
    AIDS Patient Care STDS; 2024 Feb; 38(2):51-60. PubMed ID: 38381948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis.
    Wood SM; Lee S; Barg FK; Castillo M; Dowshen N
    J Adolesc Health; 2017 May; 60(5):549-555. PubMed ID: 28132744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers to uptake of PrEP across the continuum among transgender women: A global scoping review.
    Teng F; Sha Y; Fletcher LM; Welsch M; Burns P; Tang W
    Int J STD AIDS; 2023 Apr; 34(5):299-314. PubMed ID: 36793197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up.
    Krakower DS; Ware NC; Maloney KM; Wilson IB; Wong JB; Mayer KH
    AIDS Patient Care STDS; 2017 Jul; 31(7):297-304. PubMed ID: 28574774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
    Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
    BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
    Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
    Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptability of PrEP among MSM and transgender communities-Qualitative findings from two metropolitan cities in India.
    Ramanaik S; Sinha AP; Mukherjee A; Pujar A; Subramanyam K; Gopalan A; Washington R
    PLoS One; 2023; 18(2):e0281984. PubMed ID: 36812258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-related care for transgender people: A systematic review of studies from around the world.
    Vaitses Fontanari AM; Zanella GI; Feijó M; Churchill S; Rodrigues Lobato MI; Costa AB
    Soc Sci Med; 2019 Jun; 230():280-294. PubMed ID: 31035207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Promising PrEP Navigation Intervention for Transgender Women and Men Who Have Sex with Men Experiencing Multiple Syndemic Health Disparities.
    Reback CJ; Clark KA; Rünger D; Fehrenbacher AE
    J Community Health; 2019 Dec; 44(6):1193-1203. PubMed ID: 31317438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barriers to Accessing and Engaging in HIV Preventive Care and Pre-Exposure Prophylaxis Experienced by Transgender Women in Florida.
    Maragh-Bass AC; Kiplagat S; Lavari S; Sastre F; Devieux JG; Jimenez D; Clarke RD; Noel I; Schrimshaw EW; Sevelius J; Cyrus E
    Int J Environ Res Public Health; 2024 Mar; 21(3):. PubMed ID: 38541377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-exposure Prophylaxis Awareness and Use Among Transgender and Nonbinary Individuals in Canada.
    Hallarn J; Scheim AI; Bauer GR
    J Acquir Immune Defic Syndr; 2024 Aug; 96(4):341-349. PubMed ID: 38916428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved PrEP Awareness and Use among Trans Women in San Francisco, California.
    Wilson EC; Hernandez CJ; Scheer S; Trujillo D; Arayasirikul S; Sicro S; McFarland W
    AIDS Behav; 2022 Feb; 26(2):596-603. PubMed ID: 34390435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PrEP Use and Correlates of Use Among a Large, Urban Sample of Men and Transgender Persons Who Have Sex with Men.
    Rathakrishnan D; Purpura LJ; Salcuni PM; Myers JE; Wahnich A; Daskalakis DC; Edelstein ZR
    AIDS Behav; 2022 Apr; 26(4):1017-1025. PubMed ID: 34599419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.